Author Archives: Tricia Schneider

UCLA Enrolls their First PARITY Participant!

Congratulations to Dr. Nicholas Bernthal and his research team at University of California Los Angeles Medical Centre for enrolling their first PARITY participant! 

Thank you to all who continue to screen new patients that present to clinic with a bone tumor of the femur or tibia for inclusion in the study. Keep up the momentum in our final months of recruitment!

PARITY Trial Reaches 95% enrollment!

We are excited to announce the PARITY trial has reached 95% of it’s enrollment target. There are only 30 participants left to enroll! Please continue to screen all new patients that present to clinic with a bone tumor of the femur or tibia for inclusion in the study.

PARITY Trial Enrolls 550 Participants!

We are excited to announce the PARITY trial has enrolled 550 participants! Keep screening all new patients that present to clinic with a bone tumor of the femur or tibia for inclusion in the study to reach our target recruitment of 600 participants before the end of 2019!

PARITY Trial Enrolment Reaches 90%!

The PARITY team is excited to announce the trial has achieved the 90% enrolment milestone! On March 23rd, the 540th participant was enrolled in the study by Dr. Shah Alam Khan and his research team at All India Institute of Medical Sciences. Thank you for everyone’s commitment in making PARITY trial a success. Remember to continue to screen all new patients that  present to clinic with a bone tumor of the femur or tibia for inclusion in the study.

University Medical Center Groningen enrolls their First Participant!

Congratulations to Dr. Paul Jutte and his research team at University Medical Center Groningen for enrolling their first PARITY participant on February 19th 2018!

Thank you to all those who continue to screen patients that present to clinic with a bone tumor of the femur or tibia for inclusion in the trial. Let’s keep the momentum going to make 2019 our final year of recruitment!

Medical University Graz Enrolls their First Participant!

Congratulations to Dr. Marko Bergovec and his research team at Medical University Graz for enrolling their first PARITY participant on February 11th 2018!

Thank you to all those who continue to screen patients that present to clinic with a bone tumor of the femur or tibia for inclusion in the trial. Let’s keep the momentum going to make 2019 our final year of recruitment!